Follow
Mattias Sandström
Mattias Sandström
PhD, Uppsala Universitet
Verified email at akademiska.se - Homepage
Title
Cited by
Cited by
Year
Individualized dosimetry of kidney and bone marrow in patients undergoing 177Lu-DOTA-octreotate treatment
M Sandström, U Garske-Román, D Granberg, S Johansson, C Widström, ...
Journal of Nuclear Medicine 54 (1), 33-41, 2013
2752013
Radionuclide Therapy of HER2-Positive Microxenografts Using a 177Lu-Labeled HER2-Specific Affibody Molecule
V Tolmachev, A Orlova, R Pehrson, J Galli, B Baastrup, K Andersson, ...
Cancer research 67 (6), 2773-2782, 2007
2742007
First-in-human molecular imaging of HER2 expression in breast cancer metastases using the 111In-ABY-025 affibody molecule
J Sörensen, D Sandberg, M Sandström, A Wennborg, J Feldwisch, ...
Journal of nuclear medicine 55 (5), 730-735, 2014
2662014
Measuring HER2-receptor expression in metastatic breast cancer using [68Ga] ABY-025 Affibody PET/CT
J Sörensen, I Velikyan, D Sandberg, A Wennborg, J Feldwisch, ...
Theranostics 6 (2), 262, 2016
2522016
Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and …
U Garske-Román, M Sandström, K Fröss Baron, L Lundin, P Hellman, ...
European journal of nuclear medicine and molecular imaging 45, 970-988, 2018
2372018
Synthetic affibody molecules: a novel class of affinity ligands for molecular imaging of HER2-expressing malignant tumors
A Orlova, V Tolmachev, R Pehrson, M Lindborg, T Tran, M Sandstrom, ...
Cancer research 67 (5), 2178-2186, 2007
2372007
Dose response of pancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy using 177Lu-DOTATATE
E Ilan, M Sandström, C Wassberg, A Sundin, U Garske–Román, ...
Journal of nuclear medicine 56 (2), 177-182, 2015
2272015
Individualized dosimetry in patients undergoing therapy with 177Lu-DOTA-D-Phe1-Tyr3-octreotate
M Sandström, U Garske, D Granberg, A Sundin, H Lundqvist
European journal of nuclear medicine and molecular imaging 37, 212-225, 2010
1972010
Quantitative and qualitative intrapatient comparison of 68Ga-DOTATOC and 68Ga-DOTATATE: net uptake rate for accurate quantification
I Velikyan, A Sundin, J Sörensen, M Lubberink, M Sandström, ...
Journal of Nuclear Medicine 55 (2), 204-210, 2014
1912014
Regional lung perfusion estimated by electrical impedance tomography in a piglet model of lung collapse
JB Borges, F Suarez-Sipmann, SH Bohm, G Tusman, A Melo, E Maripuu, ...
Journal of applied physiology 112 (1), 225-236, 2012
1892012
Regional lung perfusion estimated by electrical impedance tomography in a piglet model of lung collapse
JB Borges, F Suarez-Sipmann, SH Bohm, G Tusman, A Melo, E Maripuu, ...
Journal of applied physiology 112 (1), 225-236, 2012
1892012
Comparative biodistribution and radiation dosimetry of 68Ga-DOTATOC and 68Ga-DOTATATE in patients with neuroendocrine tumors
M Sandström, I Velikyan, U Garske-Román, J Sörensen, B Eriksson, ...
Journal of Nuclear Medicine 54 (10), 1755-1759, 2013
1642013
Affibody molecules for epidermal growth factor receptor targeting in vivo: aspects of dimerization and labeling chemistry
V Tolmachev, M Friedman, M Sandström, TLJ Eriksson, D Rosik, M Hodik, ...
Journal of Nuclear Medicine 50 (2), 274-283, 2009
1472009
Imaging of EGFR expression in murine xenografts using site-specifically labelled anti-EGFR 111In-DOTA-ZEGFR:2377 Affibody molecule: aspect of the injected …
V Tolmachev, D Rosik, H Wållberg, A Sjöberg, M Sandström, M Hansson, ...
European journal of nuclear medicine and molecular imaging 37, 613-622, 2010
1432010
99mTc-maEEE-ZHER2:342, an Affibody Molecule-Based Tracer for the Detection of HER2 Expression in Malignant Tumors
T Tran, T Engfeldt, A Orlova, M Sandström, J Feldwisch, L Abrahmsén, ...
Bioconjugate chemistry 18 (6), 1956-1964, 2007
1392007
Evaluation of maleimide derivative of DOTA for site-specific labeling of recombinant affibody molecules
S Ahlgren, A Orlova, D Rosik, M Sandström, A Sjöberg, B Baastrup, ...
Bioconjugate chemistry 19 (1), 235-243, 2008
1372008
Biodistribution and radiation dosimetry of the anti-HER2 affibody molecule 68Ga-ABY-025 in breast cancer patients
M Sandström, K Lindskog, I Velikyan, A Wennborg, J Feldwisch, ...
Journal of Nuclear Medicine 57 (6), 867-871, 2016
1192016
Targeting of HER2-expressing tumors using 111In-ABY-025, a second-generation affibody molecule with a fundamentally reengineered scaffold
S Ahlgren, A Orlova, H Wållberg, M Hansson, M Sandström, R Lewsley, ...
Journal of nuclear medicine 51 (7), 1131-1138, 2010
1192010
A HER2-binding Affibody molecule labelled with 68Ga for PET imaging: direct in vivo comparison with the 111In-labelled analogue
V Tolmachev, I Velikyan, M Sandström, A Orlova
European journal of nuclear medicine and molecular imaging 37, 1356-1367, 2010
1012010
Dosimetry-based treatment planning for molecular radiotherapy: a summary of the 2017 report from the Internal Dosimetry Task Force
C Stokke, PM Gabiña, P Solný, F Cicone, M Sandström, KS Gleisner, ...
EJNMMI physics 4, 1-9, 2017
952017
The system can't perform the operation now. Try again later.
Articles 1–20